Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGNA VICTORIA: Liraglutide for Cardiovascular Dysfunction in T2DM
NCT01761318Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2013
- Primary completion
- Mar 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), cardiovascular dysfunction, sponsored by Leiden University Medical Center. Started Nov 2013; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)cardiovascular dysfunction
Beyond the preview
Go deeper on NCT01761318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01761318.